Literature DB >> 11706123

Lamotrigine in the treatment of SUNCT syndrome.

G D'Andrea1, F Granella, N Ghiotto, G Nappi.   

Abstract

Short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is considered an intractable condition. The authors treated five patients with lamotrigine (125 to 200 mg daily), obtaining a complete remission in three patients and a substantial reduction (about 80%) of attack frequency in the other two. No adverse effects were noted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706123     DOI: 10.1212/wnl.57.9.1723

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Trigeminal autonomic cephalgias.

Authors:  Manjit S Matharu; Peter J Goadsby
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 2.  Tic versus TAC: differentiating the neuralgias (trigeminal neuralgia) from the cephalalgias (SUNCT and SUNA).

Authors:  Juliana VanderPluym; Lawrence Richer
Journal:  Curr Pain Headache Rep       Date:  2015

Review 3.  SUNCT Syndrome: diagnosis and treatment.

Authors:  Juan A Pareja; Ana B Caminero; Ottar Sjaastad
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 4.  [Update on trigeminal autonomic cephalalgia].

Authors:  C Gaul; D Holle; A May
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

5.  SUNCT and SUNA: Recognition and Treatment.

Authors:  Juan A Pareja; Mónica Alvarez; Teresa Montojo
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

Review 6.  Short-lasting headache syndromes and treatment options.

Authors:  Todd D Rozen
Journal:  Curr Pain Headache Rep       Date:  2004-08

Review 7.  Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review.

Authors:  Manjit S Matharu; Anna S Cohen; Christopher J Boes; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2003-08

8.  Update on the therapy of the trigeminal autonomic cephalalgias.

Authors:  Marc E Lenaerts
Journal:  Curr Treat Options Neurol       Date:  2008-01       Impact factor: 3.598

Review 9.  Management of trigeminal autonomic cephalgias and hemicrania continua.

Authors:  Manjit S Matharu; Christopher J Boes; Peter J Goadsby
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Trigeminal autonomic cephalalgias: A review of recent diagnostic, therapeutic and pathophysiological developments.

Authors:  Giorgio Lambru; Manjit S Matharu
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.